echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Liver Int: The effect of direct antiviral therapy on long-term blood glucose control of type 2 diabetes with chronic hepatitis or cirrhosis

    Liver Int: The effect of direct antiviral therapy on long-term blood glucose control of type 2 diabetes with chronic hepatitis or cirrhosis

    • Last Update: 2021-05-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Hepatitis C virus (HCV) is one of the main causes of liver disease worldwide.


    diabetes

    This study aims to evaluate the effect of anti-HCV direct-acting antiviral (DAA) treatment on long-term blood glucose control in patients with chronic hepatitis C (CHC) or cirrhosis of type 2 diabetes (HCV/T2DM) .


    To evaluate the effect of anti-HCV direct-acting antiviral (DAA) treatment on long-term blood glucose control in patients with chronic hepatitis C (CHC) or cirrhosis of type 2 diabetes (HCV/T2DM)

    The study included 182 HCV/T2DM patients who had achieved virus clearance through DAA treatment.


    HbA1c levels at each time node of the two groups of patients

    HbA1c levels at each time node of the two groups of patients

    At baseline, the average value of glycosylated hemoglobin (HbA1c) in the total study population was 7.


    The HbA1c variant evaluation showed that compared with the baseline of CHC patients, blood glucose control was significantly improved at all time points after treatment.


    Using DAA-based programs to cure HCV can significantly and continuously improve the blood glucose control of type 2 diabetic patients with chronic hepatitis.


    Original source:

    Cacciola Irene,Russo Giuseppina,Filomia Roberto et al.


    org/10.
    1111/liv.
    14905" target="_blank" rel="noopener">Over time evaluation of glycaemic control in direct -acting-antiviral treated HCV / diabetic individuals with chronic hepatitis or with cirrhosis in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.